10-QPeriod: Q2 FY2005

CVS HEALTH Corp Quarterly Report for Q2 Ended Apr 2, 2005

Filed May 9, 2005For Securities:CVS

Summary

CVS Corporation reported a strong first quarter for fiscal year 2005, with net sales increasing by 34.7% to $9.2 billion, largely driven by the acquisition of Eckerd's retail drugstores and pharmacy benefit management businesses in July 2004. Net earnings also saw a significant rise of 18.4% to $289.7 million, or $0.69 per diluted share, compared to the prior year. The company continues to expand its store base, opening 51 new stores and relocating 45 during the quarter, while maintaining solid same-store sales growth of 8.2%. While the acquisition has boosted top-line growth and expanded market presence, it also led to an increase in operating expenses and interest expense due to higher debt levels. Net cash provided by operating activities saw a significant decrease, primarily due to increased inventory purchases to support the newly acquired stores. Despite these operational shifts, CVS demonstrates a continued commitment to growth through strategic acquisitions and store development, supported by a solid credit rating and access to financing. Investors should monitor the integration of the Eckerd assets and the impact of generic drug conversions on future margins.

Key Highlights

  • 1Net sales surged by 34.7% to $9.2 billion in Q1 2005, significantly boosted by the Eckerd acquisition.
  • 2Net earnings increased by 18.4% to $289.7 million, with diluted EPS at $0.69.
  • 3Same-store sales showed healthy growth of 8.2% across all segments.
  • 4The company expanded its retail footprint, operating 5,409 stores by the end of the quarter.
  • 5Operating expenses and interest expense rose due to the integration of acquired businesses and increased debt.
  • 6Net cash provided by operating activities decreased significantly due to higher inventory levels.
  • 7CVS is actively managing legal proceedings, with an agreement in principle for settlement of securities litigation.
  • 8The company maintained strong credit ratings ('A3' by Moody's, 'A-' by S&P) supporting its financing capabilities.

Frequently Asked Questions

The primary driver of the significant sales growth was the acquisition of Eckerd Corporation's retail drugstores and pharmacy benefit management businesses in July 2004. This acquisition contributed approximately 23.9% to the total net sales increase.

The acquisition led to an increase in total operating expenses and interest expense, as these acquired businesses have higher operating expenses as a percentage of sales and the acquisition was funded by debt. Additionally, net cash provided by operating activities decreased primarily due to increased inventory purchases to support the newly acquired stores.

CVS plans to continue its expansion strategy. In the first quarter, they opened 51 new stores and relocated 45. For fiscal year 2005, the company plans to open 275-300 new stores, including approximately 125 relocations. By the end of the first quarter, they operated 5,409 retail and specialty pharmacy stores.

Yes, CVS is involved in securities litigation and a shareholder derivative suit related to alleged securities fraud. The company has reached an agreement in principle to settle both actions, which is expected to be paid for primarily by insurers and not have a material impact on the financial statements.